| Code | 7910D | ||||||||||
| MA number | 18/0172/21-S | ||||||||||
| Product Form: | tbl 336x50 mg (blis.PA/Al/PVC/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Vipharm S.A., Poland | ||||||||||
| Therapeutic Class: | 18 - ANTIDIABETICA (VRÁTANE INZULÍNU) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister PA/Al/PVC/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 28.06.2021 |
| Validity: | 28.06.2026 |
| SPC: |
SPC_Anvildis 50 mg_06 2021.pdf
|
| PIL: |
PIL_Anvildis 50 mg_06 2021.pdf
|
| Safety feature | Yes |
| Data update: | 04.08.2025 |
